First FDA-approved OTC topical pain relief patch released

MANILA, Philippines - Hisamitsu Pharmaceutical Co. Inc., a world leader in the manufacture of external pain-relieving drugs, has announced the release of its newly developed topical analgesic, the new Salonpas Pain Relief Patch.

The newly developed topical analgesic, which comes with an improved formula that penetrates quickly and targets pain, is the first and only US FDA-approved over-the-counter (OTC) topical pain relief patch in the market today.

By launching the new Salonpas Pain Relief Patch in the Philippine over-the-counter market, Hisamitsu aims to continue to promote people’s health, and to do so by delivering pharmaceutical substances in safe, efficacious, and convenient transdermal patches.

Originally developed in Japan, the Salonpas Pain Relief Patch is formulated to provide temporary relief of mild to moderate muscle aches and pains associated with arthritis, sprains, strains, bruises, and simple backaches experienced by patients aged 12 and older.

Each thin, and stretchable patch contains 10 percent methyl salicylate and three percent l-menthol as active ingredients, which are absorbed through the skin to directly target the site of pain for fast-acting, long-lasting relief.